S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
NASDAQ:AQB

AquaBounty Technologies Stock Forecast, Price & News

$12.07
+1.12 (+10.23 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.97
Now: $12.07▼
$12.20
50-Day Range
$8.09
MA: $9.49▼
$11.53
52-Week Range
$1.52
Now: $12.07▼
$12.34
Volume2.24 million shs
Average Volume2.91 million shs
Market Capitalization$542.68 million
P/E RatioN/A
Dividend YieldN/A
Beta1.27
AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts.
AquaBounty Technologies logo

MarketRank™

Overall MarketRank™

1.43 out of 5 stars

Medical Sector

520th out of 1,922 stocks

Fishing, Hunting & Trapping Industry

1st out of 5 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Fishing, hunting & trapping
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AQB
Previous Symbol
CUSIPN/A
CIK1603978
Webwww.aquabounty.com
Phone978-648-6000
Employees71

Debt

Debt-to-Equity Ratio0.14
Current Ratio18.33
Quick Ratio17.10

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$190,000.00
Price / Sales2,856.21
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.10 per share
Price / Book10.97

Profitability

EPS (Most Recent Fiscal Year)($0.66)
Net Income$-13,230,000.00
Net Margins-11,050.81%
Return on Equity-36.77%
Return on Assets-30.50%

Miscellaneous

Outstanding Shares44,961,000
Market Cap$542.68 million
Next Earnings Date3/9/2021 (Estimated)
OptionableNot Optionable
$12.07
+1.12 (+10.23 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AQB News and Ratings via Email

Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AquaBounty Technologies (NASDAQ:AQB) Frequently Asked Questions

How has AquaBounty Technologies' stock been impacted by COVID-19?

AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AQB stock has increased by 552.4% and is now trading at $12.07.
View which stocks have been most impacted by COVID-19.

Is AquaBounty Technologies a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AquaBounty Technologies stock.
View analyst ratings for AquaBounty Technologies or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than AquaBounty Technologies?

Wall Street analysts have given AquaBounty Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AquaBounty Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is AquaBounty Technologies' next earnings date?

AquaBounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for AquaBounty Technologies.

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) released its quarterly earnings data on Tuesday, November, 3rd. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.01. The firm earned $0.07 million during the quarter, compared to the consensus estimate of $1.79 million. AquaBounty Technologies had a negative trailing twelve-month return on equity of 36.77% and a negative net margin of 11,050.81%.
View AquaBounty Technologies' earnings history.

What price target have analysts set for AQB?

3 analysts have issued 12 month target prices for AquaBounty Technologies' shares. Their forecasts range from $3.50 to $9.00. On average, they anticipate AquaBounty Technologies' stock price to reach $5.83 in the next year. This suggests that the stock has a possible downside of 51.7%.
View analysts' price targets for AquaBounty Technologies or view Wall Street analyst' top-rated stocks.

Who are some of AquaBounty Technologies' key competitors?

Some companies that are related to AquaBounty Technologies include Praxis Precision Medicines (PRAX), Sangamo Therapeutics (SGMO), Shattuck Labs (STTK), MEDNAX (MD), Harmony Biosciences (HRMY), Bavarian Nordic A/S (BVNRY), Silk Road Medical (SILK), Replimune Group (REPL), Owens & Minor (OMI), Addus HomeCare (ADUS), Myriad Genetics (MYGN), PMV Pharmaceuticals (PMVP), NGM Biopharmaceuticals (NGM), Pharma Mar (PHMMF) and Kura Oncology (KURA).
View all of AQB's competitors.

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Aurora Cannabis (ACB), Allena Pharmaceuticals (ALNA), Evofem Biosciences (EVFM) and Rigel Pharmaceuticals (RIGL).

Who are AquaBounty Technologies' key executives?

AquaBounty Technologies' management team includes the following people:
  • Ms. Sylvia A. Wulf, CEO, Pres & Exec. Director (Age 63, Pay $383.17k)
  • Mr. David A. Frank, CFO & Treasurer (Age 61, Pay $282.8k)
  • Dr. Alejandro Rojas, Chief Operating Officer of AquaBounty Farms (Age 59, Pay $234.1k)
  • Dr. Mark Walton, Chief Technology Officer
  • Ms. Angela M. Olsen J.D., Gen. Counsel & Corp. Sec. (Age 52)
  • Dave Conley, Director of Communications
  • Mr. David F. Melbourne Jr., Chief Commercial Officer
  • Mr. Louis H. Barnett, Financial Advisor

What is AquaBounty Technologies' stock symbol?

AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."

Who are AquaBounty Technologies' major shareholders?

AquaBounty Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Epiq Partners LLC (1.46%). Company insiders that own AquaBounty Technologies stock include David A Frank, Randal J Kirk, Richard L Huber and Rick L Sterling.
View institutional ownership trends for AquaBounty Technologies.

Which institutional investors are selling AquaBounty Technologies stock?

AQB stock was sold by a variety of institutional investors in the last quarter, including Epiq Partners LLC.
View insider buying and selling activity for AquaBounty Technologies or view top insider-selling stocks.

How do I buy shares of AquaBounty Technologies?

Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AquaBounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $12.07.

How big of a company is AquaBounty Technologies?

AquaBounty Technologies has a market capitalization of $542.68 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis. AquaBounty Technologies employs 71 workers across the globe.

What is AquaBounty Technologies' official website?

The official website for AquaBounty Technologies is www.aquabounty.com.

How can I contact AquaBounty Technologies?

AquaBounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.